PTCE · Medications · 6 min read
Cardiovascular Drugs
- Differentiate major cardiovascular drug classes by their generic suffixes, mechanisms of action, and characteristic side effects.
- Recognize critical storage specifications, administration requirements, and safety warnings for cardiovascular medications.
- Distinguish the role of the pharmacy technician in technical order fulfillment from the clinical duties reserved for the supervising pharmacist.
Blood Pressure Regulators: ACE Inhibitors and ARBs
Managing high blood pressure is essential to cardiovascular wellness, and two core classes used to accomplish this are angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs). ACE inhibitors generally share the generic suffix '-pril', represented by drugs such as lisinopril, enalapril, and ramipril. They lower blood pressure by blocking the conversion of angiotensin I into angiotensin II, which is a potent vasoconstrictor. While performing this action, ACE inhibitors also cause an accumulation of a substance called bradykinin. This buildup frequently produces a persistent, dry cough that can be bothersome to patients.
Angiotensin II receptor blockers, commonly recognized by the suffix '-sartan', include medications such as losartan, valsartan, and olmesartan. Instead of stopping the production of angiotensin II, ARBs work downstream by blocking angiotensin II directly at its receptor sites. Because ARBs do not cause bradykinin to build up, they have a much lower incidence of dry cough compared to ACE inhibitors. An everyday comparison is stopping water flow: an ACE inhibitor turns off the main supply valve upstream, whereas an ARB caps the faucet directly.
Both ACE inhibitors and ARBs share significant clinical cautions. Both drug classes can raise serum potassium levels, creating a risk for hyperkalemia. Furthermore, both ACE inhibitors and ARBs carry boxed warnings for fetal toxicity and must be stopped as soon as pregnancy is detected. If a patient mentions an unexpected cough, asks whether they can continue their medication while pregnant, or requests an evaluation of their blood pressure therapy, the pharmacy technician must immediately transfer the inquiry to the pharmacist.
| Drug Class | Common Generic Suffix | Key Examples | Dry Cough Incidence | Safety Precautions |
|---|---|---|---|---|
| ACE Inhibitors | '-pril' | lisinopril, enalapril, ramipril | Higher (due to bradykinin accumulation) | Boxed warning for fetal toxicity; risk of hyperkalemia |
| Angiotensin II Receptor Blockers (ARBs) | '-sartan' | losartan, valsartan, olmesartan | Much lower (no bradykinin buildup) | Boxed warning for fetal toxicity; risk of hyperkalemia |
Common mistakes
- Assuming metoprolol tartrate and metoprolol succinate can be substituted interchangeably, forgetting that succinate is extended-release for once-daily dosing while tartrate is immediate-release.
- Repackaging dabigatran capsules or sublingual nitroglycerin tablets into standard amber plastic prescription vials, which violates their strict manufacturer packaging requirements to protect against moisture and degradation.
- Attempting to advise a patient experiencing muscle pain on a statin or bleeding gums on an anticoagulant, instead of immediately referring the clinical evaluation to the supervising pharmacist.
- Overlooking severe drug interactions, such as combining nitrates with PDE-5 inhibitors or coadministering gemfibrozil with statins, rather than halting processing and alerting the pharmacist.
Key points
- ACE inhibitors ('-pril') cause cough through bradykinin accumulation, while ARBs ('-sartan') avoid this pathway; both raise potassium and carry boxed warnings for fetal toxicity.
- Beta blockers ('-olol') reduce heart rate and blood pressure while masking hypoglycemic tremors and tachycardia; metoprolol succinate is extended-release whereas metoprolol tartrate is immediate-release.
- Diuretics include potassium-wasting loop and thiazide agents, as well as potassium-sparing drugs like spironolactone, which acts as an aldosterone antagonist and can cause gynecomastia.
- Nitrates dilate veins to relieve angina but are strictly contraindicated with PDE-5 inhibitors, and sublingual nitroglycerin tablets must stay in their original glass container.
- Statins ('-statin') inhibit hepatic cholesterol synthesis, can cause myopathy or rhabdomyolysis, may be affected by grapefruit juice, and carry increased muscle toxicity risks when taken with gemfibrozil.
- Anticoagulants and antiplatelet agents increase bleeding risks, with warfarin requiring INR tracking and dietary consistency, and dabigatran requiring protection from moisture in original packaging.
- Pharmacy technicians ensure accurate product selection, labeling, and storage, but must refer all clinical questions, patient reports of bleeding, and therapy alerts to the pharmacist for final verification.
Practice this section
Explained PTCE Medications questions, no account needed. PTCE Medications practice test
The full lesson continues with 4 more sections with exam tips, audio in English and Spanish, 5 Check yourself questions and 20 flashcards.
- 1 month
$44.99$22.49 - 3 months
$131.99$65.99 - Lifetime
$269.99$134.99
One payment, no subscription.
See PTCE plansAlready a member? Log in
Sample lesson: Generic and Brand Names, Indications and OTC Products25 practice questions on this exam
Each PTCE practice test has 25 original questions with the answers explained. No account needed.
Open the PTCE practice testsOriginal lesson written for PTCE practice · updated October 15, 2026. Exam names are trademarks of their owners; tests.global is not affiliated with them.